Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 09 May 2011
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Drug-induced dyskinesia; Parkinson's disease
- Focus Therapeutic Use
- 09 May 2011 New trial record